The US and UK Reach Agreement in Principle on Pharmaceuticals, Pharmaceutical Ingredients, and Medical Technology By Husch Blackwell Trade Team on December 2, 2025 Posted in First 100 Days of Trade, International Trade & Supply Chain, Trade Policy Exempt U.K.-origin pharmaceuticals, pharmaceutical ingredients, and medical technology from Section 232 tariffs; Refrain from targeting U.K. pharmaceutical pricing practices in any future Section 301 investigation for the …